Association of N-terminal pro-B natriuretic peptide with all-cause mortality and cardiovascular mortality in obese and non-obese populations and the development of a machine learning prediction model: National Health and Nutrition Examination Survey (NHANES) 1999-2004.

Journal: Diabetes, obesity & metabolism
PMID:

Abstract

AIMS: To explore the potential of N-terminal pro-B natriuretic peptide (NTproBNP) in identifying adverse outcomes, particularly cardiovascular adverse outcomes, in a population with obesity, and to establish a risk prediction model.

Authors

  • Han Zhou
    Jiangsu Provincial Key Laboratory of Special Robot Technology, Hohai University, Changzhou, China.
  • Chen Yang
    Department of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
  • Jingjie Li
    School of Nursing, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Lin Sun
    College of Computer and Information Engineering, Henan Normal University, Xinxiang, China.